Clinical Trial Update: Serotonin Control of Impulsivity in Tourette Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating serotonin-based approaches to impulsivity in Tourette syndrome is currently recruiting in Lyon, France, sponsored by Hospice…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tourette Syndrome

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Tourette Disorder | Phase 2 | Status: RECRUITING